Kent Lewandrowski, M.D. is the Director of Pathology Laboratories and Molecular Medicine and Associate Chief of Pathology at the Massachusetts General Hospital. He is also director of the hospital point-of-care program and the Quality Chair of the Department of Pathology. He is a Professor at Harvard Medical School with research interests in the evaluation of point-of-care technologies and outcomes studies concerning implementation of point-of-care testing. Dr. Lewandrowski was trained in anatomic and clinical pathology at the Massachusetts General Hospital and has been on the staff of the department of Pathology since 1991. He is also editor in chief of the medical journal “Point of Care: The Journal of Near Patient Testing Technologies”.